| Application no. and date | 17768863.7 (espacenet) (Federated) (European Patent Register), 20170811 | | Patent/reg. no. and date | DK/EP 3497132, 20200624 | | Publication date | 20190619 | | Priority no. and date | US 201662374986 P, 20160815 | | EP pub. no. and date |
EP 3497132 20190619 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | BT/GP/161610 | | Inventor | WALLSTRÖM, Erik, c/o Novartis Pharma AG
Postfach
4002 Basel, CH,
SAVELIEVA PRAZ, Marina, c/o Novartis Pharma AG
4002 Basel, CH,
KAKARIEKA WEISSKOPF, Algirdas Jonas, c/o Novartis Pharma AG
Postfach
4002 Basel, CH,
KAHN, Joseph Michael, c/o Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover
New Jersey 07936-1080, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 25/00 (2006.01) , C07K 16/28 (2006.01) | | Title | Regimer og fremgangsmåder til behandling af multipel sclerose under anvendelse af ofatumumab | | Int. application no. | IB2017054909 | | Int. publication no. | WO2018033841 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
